DRONABINOL
Tracking # 20-817067
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
DRONABINOL IS SYNTHETIC TETRAHYDROCANNABINOL ('THC'), WHICH OBTAINED FDA APPROVAL IN 1985 FOR THE TREATMENT OF HIV/AIDS-INDUCED ANOREXIA AND CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WHO HAVE FAILED TO RESPOND TO CONVENTIONAL ANTIEMETICS. DRONABINOL HAS ALSO BEEN USED OFF-LABEL FOR THE TREATMENT OF OSA. THIS ACTIVITY WILL PROVIDE AN OVERVIEW OF THE PHARMACOLOGY OF DRONABINOL, ITS INDICATIONS AND USAGE, ADVERSE EFFECTS, CONTRAINDICATIONS, AND OTHER PERTINENT INFORMATION.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.25h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.25h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.25h
AMA Category I
Physician Assistant
1.25h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.25h
AMA Category I